Latest news

• Lilly’s president and chief executive John Lechleiter to retire

  Sales of blockbuster lung cancer treatment Alimta (pemetrexed disodium) have suffered with UK and German courts ruling in favour of the generic competition, while patents for Lilly's osteoporosis drug Evista

• UK court backs Actavis in dispute over Lilly's Alimta

  Alimta. The UK High Court has ruled that a patent held by Lilly on a vitamin regimen for Alimta (pemetrexed disodium) - a series of vitamin B12 injections used to reduce the ... The compound patent on pemetrexed disodium expired in December 2015 in most

• German court overturns patent on Lilly blockbuster Alimta

  The patent challenge was not for the compound patent on pemetrexed disodium - the active ingredient in Alimta - but for a vitamin regimen used alongside the drug that is designed to limit ... The generic drugmaker is developing a different salt for of